Michael H. Davidson's Net Worth
$3.72 Million
Who is Michael H. Davidson?
Michael H. Davidson has an estimated net worth of $3.72 Million. This is based on reported shares across multiple companies, which include Omthera Pharmaceuticals, Inc., TENAX THERAPEUTICS, INC., Caladrius Biosciences, Inc., and NewAmsterdam Pharma Co N.V..
SEC CIK
Michael H. Davidson's CIK is 0001573785
Past Insider Trading and Trends
2024 was Michael H. Davidson's most active year for acquiring shares with 6 total transactions. Michael H. Davidson's most active month to acquire stocks was the month of May. 2013 was Michael H. Davidson's most active year for disposing of shares, totalling 2 transactions. Michael H. Davidson's most active month to dispose stocks was the month of March. 2020 saw Michael H. Davidson paying a total of $219,943.05 for 106,588 shares, this is the most they've acquired in one year. In 2013 Michael H. Davidson cashed out on 1,037,087 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Omthera Pharmaceuticals, Inc. No price found
Executive VP & CMOMichael H. Davidson used to own units in Common Stock but no longer holds any shares there. In the year 2013 Michael H. Davidson filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.49M |
—
|
—
|
0
|
Jul 18
| |||
Form 4
| +5.69% | 51.96K |
—
|
—
| 964.59K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TENAX THERAPEUTICS, INC. (TENX) Snapshot price: $3.87
InvestorMichael H. Davidson owns 2,881 units of Common Stock which is worth $11,149.47. From 2021 to 2024 Michael H. Davidson acquired a total of 514,500 shares in TENAX THERAPEUTICS, INC..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +656.17% | 2.5K |
—
|
—
| 2.88K |
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +540.97% | 512K |
—
|
—
| 606.64K |
Jun 10 - Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caladrius Biosciences, Inc. (LSTA) Snapshot price: $3.13
InvestorMichael H. Davidson owns 209,753 units of Common Stock which is worth $656,526.89. In the year 2020 Michael H. Davidson filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.34% | 65.43K |
—
|
—
| 209.75K |
Jan 10
| |||
Form 4
| +35.40% | 37.73K |
—
|
—
| 144.32K |
Jan 11
| |||
Form 4
| +108.74% | 55.52K |
$1.80 | $99,945.00 | 106.59K |
Sep 9
| |||
Form 4
|
∞
| 51.06K |
$2.35 | $119,998.05 | 51.06K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NewAmsterdam Pharma Co N.V. (NAMS) Snapshot price: $16.4
Chief Executive OfficerMichael H. Davidson owns 209,784 units of Ordinary Shares which is worth $3,440,457.60. In the year 2024 Michael H. Davidson filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.44% | 5K |
$16.27 | $81,350.00 | 209.78K |
Aug 20
| |||
Form 4
| +2.50% | 5K |
$17.26 | $86,308.50 | 204.78K |
Jun 20
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||